Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19 (PROTECT-Surg)
Sponsor: Christian Medical College and Hospital, Ludhiana, India
Suspended
Lack of IMP availability - may resume.
A PHASE3 clinical study on COVID and Pulmonary Complications in Surgical Patients, this trial is suspended. The trial is conducted by Christian Medical College and Hospital, Ludhiana, India and has accumulated 9 data snapshots since 2022. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
9 versions recorded-
Jun 2025 — Present [monthly]
Suspended PHASE3
-
Mar 2025 — Jun 2025 [monthly]
Suspended PHASE3
Status: Not Yet Recruiting → Suspended
-
Sep 2024 — Mar 2025 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE3
-
Sep 2021 — Jul 2024 [monthly]
Not Yet Recruiting PHASE3
▶ Show 4 earlier versions
-
May 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2021 — May 2021 [monthly]
Not Yet Recruiting PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jun 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Christian Medical College and Hospital, Ludhiana, India
- Hospital Español Veracruz
- Istituto Clinico Humanitas
- Kigali University Teaching Hospital
- Ministry of Health, Ghana
- University of Birmingham
- University of Cape Town
- University of Edinburgh
- University of Lagos, Nigeria
- University of Witwatersrand, South Africa
- Université d'Abomey-Calavi
For direct contact, visit the study record on ClinicalTrials.gov .